m+Medelevator.RU
← Поиск публикаций
Best practice & research. Clinical rheumatology · 2021

A comprehensive framework for navigating patient care in systemic sclerosis: A global response to the need for improving the practice of diagnostic and preventive strategies in SSc.

СтатьяПоддержка NIH: внешняя программаПоддержка исследования: вне правительства СШАОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Saketkoo Lesley Ann, Frech Tracy, Varjú Cecília, Domsic Robyn, Farrell Jessica, Gordon Jessica K, Mihai Carina, Sandorfi Nora, Shapiro Lee, Poole Janet, Volkmann Elizabeth R, Lammi Monika, McAnally Kendra, Alexanderson Helene, Pettersson Henrik, Hant Faye, Kuwana Masataka, Shah Ami A, Smith Vanessa, Hsu Vivien, Kowal-Bielecka Otylia, Assassi Shervin, Cutolo Maurizio, Kayser Cristiane, Shanmugam Victoria K, Vonk Madelon C, Fligelstone Kim, Baldwin Nancy, Connolly Kerri, Ronnow Anneliese, Toth Beata, Suave Maureen, Farrington Sue, Bernstein Elana J, Crofford Leslie J, Czirják László, Jensen Kelly, Hinchclif Monique, Hudson Marie, Lammi Matthew R, Mansour Jennifer, Morgan Nadia D, Mendoza Fabian, Nikpour Mandana, Pauling John, Riemekasten Gabriela, Russell Anne-Marie, Scholand Mary Beth, Seigart Elise, Rodriguez-Reyna Tatiana Sofia, Hummers Laura, Walker Ulrich, Steen Virginia

Аннотация

Systemic sclerosis (SSc), the most lethal of rheumatologic conditions, is the cause of death in >50% of SSc cases, led by pulmonary fibrosis followed by pulmonary hypertension and then scleroderma renal crisis (SRC). Multiple other preventable and treatable SSc-related vascular, cardiac, gastrointestinal, nutritional and musculoskeletal complications can lead to disability and death. Vascular injury with subsequent inflammation transforming to irreversible fibrosis and permanent damage characterizes SSc. Organ involvement is often present early in the disease course of SSc, but requires careful history-taking and vigilance in screening to detect. Inflammation is potentially reversible provided that treatment intensity quells inflammation and other immune mechanisms. In any SSc phenotype, opportunities for early treatment are prone to be under-utilized, especially in slowly progressive phenotypes that, in contrast to severe progressive ILD, indolently accrue irreversible organ damage resulting in later-stage life-limiting complications such as pulmonary hypertension, cardiac involvement, and malnutrition. A single SSc patient visit often requires much more physician and staff time, organization, vigilance, and direct management for multiple organ systems compared to other rheumatic or pulmonary diseases. Efficiency and efficacy of comprehensive SSc care enlists trending of symptoms and bio-data. Financial sustainability of SSc care benefits from understanding insurance reimbursement and health system allocation policies for complex patients. Sharing care between recognised SSc centers and local cardiology/pulmonary/rheumatology/gastroenterology colleagues may prevent complications and poor outcomes, while providing support to local specialists. As scleroderma specialists, we offer a practical framework with tools to facilitate an optimal, comprehensive and sustainable approach to SSc care. Improved health outcomes in SSc relies upon recogntion, management and, to the extent possible, prevention of SSc and treatment-related complications.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты